Literature DB >> 24929678

Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel.

Müjgan Dogan Onugoren1, Helmut Rauschka2, Christian G Bien3.   

Abstract

Antibodies (abs) to the GABAB receptor have been recently found to be responsible for immune-mediated encephalitis with dominant seizures. They are in approximately 50% of cases associated with small-cell lung cancer (SCLC). GABAB receptors are mainly located in the hippocampus, thalamus and cerebellum in the presynaptic and postsynaptic regions of synapses. The main function of these receptors is to reduce activity states of neurons. In some instances, GABAB receptor abs in these patients were accompanied by other antibodies, among them VGCC abs (Lancaster et al., 2010, Boronat et al., 2011). VGCC abs cause paraneoplastic Lambert Eaton myasthenic syndrome (LEMS) by reduction of presynaptic VGCCs (Titulaer et al., 2011). In the domain of CNS disease, VGCC abs have been found in association with paraneoplastic cerebellar ataxia (Mason et al., 1997) and rarely and at low titres also in other paraneoplastic encephalopathies together with Hu abs (Lennon et al., 1995). It has been a long-standing debate if abs in paraneoplastic conditions associate rather with the neurological syndrome or the tumour. Here, we describe the conjoint occurrence of abs to the GABAB receptor and to the VGCC in a patient with SCLC presenting only symptoms of the peripheral nervous system giving another example of the latter hypothesis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GABA(B) receptor antibodies; Lambert–Eaton myasthenic syndrome; Paraneoplastic antibodies; Voltage gated calcium channel antibodies

Mesh:

Substances:

Year:  2014        PMID: 24929678     DOI: 10.1016/j.jneuroim.2014.05.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.

Authors:  Romana Höftberger; Theodor W May; Christian G Bien; Corinna I Bien; Müjgan Dogan Onugoren; Desiree De Simoni; Verena Eigler; Carl-Albrecht Haensch; Martin Holtkamp; Fatme S Ismail; Martin Kurthen; Nico Melzer; Kristina Mayer; Felix von Podewils; Helmut Rauschka; Andrea O Rossetti; Wolf-Rüdiger Schäbitz; Olga Simova; Karsten Witt
Journal:  J Neurol       Date:  2020-04-03       Impact factor: 4.849

2.  Limbic Encephalitis Associated with Anti-γ-aminobutyric Acid B Receptor Antibodies: A Case Series from China.

Authors:  Hong-Zhi Guan; Hai-Tao Ren; Xun-Zhe Yang; Qiang Lu; Bin Peng; Yi-Cheng Zhu; Xiao-Qiu Shao; Yong-Qiang Hu; Dong Zhou; Li-Ying Cui
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

Review 3.  Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.

Authors:  Nese Sinmaz; Tina Nguyen; Fiona Tea; Russell C Dale; Fabienne Brilot
Journal:  J Neuroinflammation       Date:  2016-08-30       Impact factor: 8.322

4.  Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report.

Authors:  Hongfang Li; Aimei Zhang; Yanlei Hao; Hongzhi Guan; Zhanyun Lv
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

5.  Pathogenic potential of antibodies to the GABAB receptor.

Authors:  Anjan Nibber; Edward O Mann; Philippa Pettingill; Patrick Waters; Sarosh R Irani; Dimitri M Kullmann; Angela Vincent; Bethan Lang
Journal:  Epilepsia Open       Date:  2017-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.